0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Clinicopathologic Reports, Case Reports, and Small Case Series |

Rapidly Progressive T-Cell Lymphoma of the Conjunctiva FREE

Carol L. Shields, MD; Jerry A. Shields, MD; Ralph C. Eagle, MD
Arch Ophthalmol. 2002;120(4):508-509. doi:.
Text Size: A A A
Published online

Conjunctival lymphoma classically presents as a salmon-colored infiltrate that evolves slowly over months to years.1 It is nearly always of B-cell lineage.1,2 In an analysis of ocular adnexal lymphoid tumors, 29% were polyclonal, 68% were monoclonal B-cell proliferations, 2% were indeterminate, 1% were null cell, and 0% were monoclonal T-cell proliferations.2 We report an unusual case of a rapidly progressive conjunctival mass that was the first manifestation of systemic T-cell lymphoma.

A 72-year-old African American woman developed swelling of her left caruncle that dramatically enlarged throughout 21 days, prompting ocular examination. Her visual acuity was 20/200 OD and counting fingers OS from cataracts bilaterally. There was a painless, pink, multinodular mass occupying 60% of the bulbar surface from the caruncle to the lateral conjunctiva, and covering half of the cornea (Figure 1). Computed tomography scans revealed preseptal soft tissue swelling without an orbital component. The patient preferred 14 days' observation while receiving topical steroid/antibiotic medication, but the mass enlarged to affect 75% of the conjunctival surface, inducing lower eyelid ectropion. Diagnostic punch biopsy was performed.

Place holder to copy figure label and caption

Clinical course of conjunctival T-cell lymphoma. A, Throughout 21 days, there occurred a dramatic growth of the conjunctival stromal mass, involving 60% of the bulbar conjunctiva. B, Histopathological examination revealed poorly cohesive pleomorphic cells, with prominent nuclei and scanty cytoplasm. Many cells displayed folded or cleaved nuclei, suggestive of T cells (hematoxylin-eosin, original magnification × 250). C, Following 3500 rad (35 Gy) of radiotherapy, the mass completely regressed.

Graphic Jump Location

Histopathological examination revealed a diffuse infiltrate of poorly cohesive medium to large cells, with moderate prominent nucleoli, and moderate, sometimes eccentric, cytoplasm. Many cells displayed folded or cleaved nuclei. Germinal centers were absent, and numerous mitotic figures were present. Immunohistochemical stains for leukocyte common antigen (CD45), UHCL-1 (CD45Ro), and CD8 were positive, suggestive of a lymphoid neoplasm of T-cell origin. B-cell marker, L26 (CD20), was negative. The final diagnosis was peripheral T-cell lymphoma.

A thorough sytemic examination revealed no systemic lymphoma or mycosis fungoides. The patient was treated with 3500 rad (35 Gy) of radiotherapy to the left conjunctiva with rapid regression of the lymphoma (Figure 1). During her last week of radiotherapy, she experienced dysphagia and a 2.72 kg weight loss. She was discovered to have an obstructive nasopharyngeal mass, and cervical, inguinal, and popliteal lymphadenopathy. On examination of the biopsy specimen, the nasopharyngeal mass proved to be T-cell lymphoma, and radiotherapy (1300 rad [13 Gy]) was delivered to the site, and there was improvement. Systemic chemotherapy, using cytoxan, vincristine, and adriamycin, was administered for 2 cycles. The patient maintained poor follow-up for 11 months, and she subsequently died of an unknown cause.

Lymphomas can be broadly classified into Hodgkin and non-Hodgkin types. Non-Hodgkin lymphomas are a diverse group and include monoclonal neoplasms of B-cell or T-cell lymphocytes. T-cell lymphomas are much less common than B-cell lymphomas and are particularly rare in the ocular region.1,2 Of the few reported cases of ophthalmic T-cell lymphomas, most involved the orbit or eyelid, and followed known systemic T-cell lymphoma.3,4 Rapid progression throughout days to weeks, and poor systemic prognosis was a common feature. Systemically, however, T-cell lymphoma can progress rapidly in aggressive subtypes or it can progress slowly as in mycosis fungoides. Cook and associates reviewed 2155 patients at the Mayo Clinic with known cutaneous T-cell lymphoma, and found infiltration of the eyelid in 0.3%, and conjunctiva in 0.05%.4 Thus, ocular involvement with T-cell lymphoma is exquisitely rare.

Using a MEDLINE search, we found one other case of T-cell lymphoma that initially presented in the conjunctiva, similar to our case.5 The conjunctival tumor in that case also showed rapid progression. The patient was a 63-year-old woman who presented with bilateral limbal conjunctival thickening and chemosis for 20 days, and histopathologic study revealed T-cell lymphoma.5 Our patient also had a rapidly enlarging conjunctival mass that began as a caruncular thickening and extended in 21 days to involve 60% of the bulbar conjunctiva. Both patients were found subsequently to have systemic T-cell lymphoma, with involvement of maxillary sinus in their case, and nasopharynx in our case. Thus, systemic evaluation is particularly important in these cases. In summary, we present an unusual case of a rapidly progressive salmon-colored conjunctival tumor that proved to be the first sign of sytemic T-cell lymphoma.

Support was provided by the Eye Tumor Research Foundation, Philadelphia, Pa (Dr C. L. Shields); the Paul Kayser International Award of Merit in Retina Research, Houston, Tex (Dr J. A. Shields); and the Noel T. and Sara L. Simmonds Endowment for Ophthalmic Pathology, Wills Eye Hospital, Philadelphia (Dr Eagle).

Corresponding author: Carol L. Shields, MD, Ocular Oncology Service, Wills Eye Hospital, 900 Walnut St, Philadelphia, PA 19107.

Shields  CLShields  JACarvalho  CRundle  PSmith  AF Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma. Ophthalmology. 2001;108979- 984
Link to Article
Jakobiec  FAKnowles  DM An overview of ocular adnexal lymphoid tumors. Trans Am Ophthalmol Soc. 1989;87420- 442
Coupland  SEFoss  HDAssaf  C  et al.  T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Ophthalmology. 1999;1062109- 2120
Link to Article
Cook  BEBartley  GBPittelkow  MR Ophthalmic abnormalities in patients with cutaneous T-cell lymphoma. Ophthalmology. 1999;1061339- 1344
Link to Article
Hu  FRLin  JCChiang  IPYeh  KH T-cell malignant lymphoma with conjunctival involvement. Am J Ophthalmol. 1998;125717- 719
Link to Article

Figures

Place holder to copy figure label and caption

Clinical course of conjunctival T-cell lymphoma. A, Throughout 21 days, there occurred a dramatic growth of the conjunctival stromal mass, involving 60% of the bulbar conjunctiva. B, Histopathological examination revealed poorly cohesive pleomorphic cells, with prominent nuclei and scanty cytoplasm. Many cells displayed folded or cleaved nuclei, suggestive of T cells (hematoxylin-eosin, original magnification × 250). C, Following 3500 rad (35 Gy) of radiotherapy, the mass completely regressed.

Graphic Jump Location

Tables

References

Shields  CLShields  JACarvalho  CRundle  PSmith  AF Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma. Ophthalmology. 2001;108979- 984
Link to Article
Jakobiec  FAKnowles  DM An overview of ocular adnexal lymphoid tumors. Trans Am Ophthalmol Soc. 1989;87420- 442
Coupland  SEFoss  HDAssaf  C  et al.  T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Ophthalmology. 1999;1062109- 2120
Link to Article
Cook  BEBartley  GBPittelkow  MR Ophthalmic abnormalities in patients with cutaneous T-cell lymphoma. Ophthalmology. 1999;1061339- 1344
Link to Article
Hu  FRLin  JCChiang  IPYeh  KH T-cell malignant lymphoma with conjunctival involvement. Am J Ophthalmol. 1998;125717- 719
Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
PubMed Articles